By delivering wild-type CASQ2 to Casq2-knockout mice, they effectively abolished adrenergically induced ventricular arrhythmias, thereby providing proof-of-concept for gene therapy in autosomal recessive CPVT. Here, CASQ2 is linked to catecholaminergic polymorphic ventricular tachycardia.